Global Cell-free DNA Mutation Diagnostics Market Research Report 2026(Status and Outlook)
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
The global Cell-free DNA Mutation Diagnostics market size was estimated at USD 8130.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell-free DNA Mutation Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell-free DNA Mutation Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell-free DNA Mutation Diagnostics market.
Global Cell-free DNA Mutation Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Natera
Guardant
Freenome Holdings
GRAIL
Exact Sciences Corporation
Foundation Medicine
Biocept
Thermo Fisher Scientific
Roche Diagnostics
Agilent Technologies
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Myriad Genetics
BillionToOne
Market Segmentation (by Type)
Kits
Instruments
Services
Market Segmentation (by Application)
Hoispital
Clinic
Laboratories
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell-free DNA Mutation Diagnostics Market
Overview of the regional outlook of the Cell-free DNA Mutation Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-free DNA Mutation Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell-free DNA Mutation Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cell-free DNA Mutation Diagnostics market size was estimated at USD 8130.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell-free DNA Mutation Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell-free DNA Mutation Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell-free DNA Mutation Diagnostics market.
Global Cell-free DNA Mutation Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Natera
Guardant
Freenome Holdings
GRAIL
Exact Sciences Corporation
Foundation Medicine
Biocept
Thermo Fisher Scientific
Roche Diagnostics
Agilent Technologies
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Myriad Genetics
BillionToOne
Market Segmentation (by Type)
Kits
Instruments
Services
Market Segmentation (by Application)
Hoispital
Clinic
Laboratories
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell-free DNA Mutation Diagnostics Market
Overview of the regional outlook of the Cell-free DNA Mutation Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-free DNA Mutation Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell-free DNA Mutation Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell-free DNA Mutation Diagnostics
1.2 Key Market Segments
1.2.1 Cell-free DNA Mutation Diagnostics Segment by Type
1.2.2 Cell-free DNA Mutation Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-free DNA Mutation Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell-free DNA Mutation Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell-free DNA Mutation Diagnostics Product Life Cycle
3.3 Global Cell-free DNA Mutation Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell-free DNA Mutation Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cell-free DNA Mutation Diagnostics Market Competitive Situation and Trends
3.8.1 Cell-free DNA Mutation Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell-free DNA Mutation Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL-FREE DNA MUTATION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Cell-free DNA Mutation Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-FREE DNA MUTATION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell-free DNA Mutation Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell-free DNA Mutation Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-free DNA Mutation Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Cell-free DNA Mutation Diagnostics Market Size by Type (2020-2025)
6.4 Global Cell-free DNA Mutation Diagnostics Price by Type (2020-2025)
7 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-free DNA Mutation Diagnostics Market Sales by Application (2020-2025)
7.3 Global Cell-free DNA Mutation Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Cell-free DNA Mutation Diagnostics Sales Growth Rate by Application (2020-2025)
8 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Cell-free DNA Mutation Diagnostics Sales by Region
8.1.1 Global Cell-free DNA Mutation Diagnostics Sales by Region
8.1.2 Global Cell-free DNA Mutation Diagnostics Sales Market Share by Region
8.2 Global Cell-free DNA Mutation Diagnostics Market Size by Region
8.2.1 Global Cell-free DNA Mutation Diagnostics Market Size by Region
8.2.2 Global Cell-free DNA Mutation Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Cell-free DNA Mutation Diagnostics Sales by Country
8.3.2 North America Cell-free DNA Mutation Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell-free DNA Mutation Diagnostics Sales by Country
8.4.2 Europe Cell-free DNA Mutation Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell-free DNA Mutation Diagnostics Sales by Region
8.5.2 Asia Pacific Cell-free DNA Mutation Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell-free DNA Mutation Diagnostics Sales by Country
8.6.2 South America Cell-free DNA Mutation Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell-free DNA Mutation Diagnostics Sales by Region
8.7.2 Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Cell-free DNA Mutation Diagnostics by Region(2020-2025)
9.2 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell-free DNA Mutation Diagnostics Production
9.4.1 North America Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell-free DNA Mutation Diagnostics Production
9.5.1 Europe Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell-free DNA Mutation Diagnostics Production (2020-2025)
9.6.1 Japan Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell-free DNA Mutation Diagnostics Production (2020-2025)
9.7.1 China Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Illumina
10.1.1 Illumina Basic Information
10.1.2 Illumina Cell-free DNA Mutation Diagnostics Product Overview
10.1.3 Illumina Cell-free DNA Mutation Diagnostics Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Natera
10.2.1 Natera Basic Information
10.2.2 Natera Cell-free DNA Mutation Diagnostics Product Overview
10.2.3 Natera Cell-free DNA Mutation Diagnostics Product Market Performance
10.2.4 Natera Business Overview
10.2.5 Natera SWOT Analysis
10.2.6 Natera Recent Developments
10.3 Guardant
10.3.1 Guardant Basic Information
10.3.2 Guardant Cell-free DNA Mutation Diagnostics Product Overview
10.3.3 Guardant Cell-free DNA Mutation Diagnostics Product Market Performance
10.3.4 Guardant Business Overview
10.3.5 Guardant SWOT Analysis
10.3.6 Guardant Recent Developments
10.4 Freenome Holdings
10.4.1 Freenome Holdings Basic Information
10.4.2 Freenome Holdings Cell-free DNA Mutation Diagnostics Product Overview
10.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Product Market Performance
10.4.4 Freenome Holdings Business Overview
10.4.5 Freenome Holdings Recent Developments
10.5 GRAIL
10.5.1 GRAIL Basic Information
10.5.2 GRAIL Cell-free DNA Mutation Diagnostics Product Overview
10.5.3 GRAIL Cell-free DNA Mutation Diagnostics Product Market Performance
10.5.4 GRAIL Business Overview
10.5.5 GRAIL Recent Developments
10.6 Exact Sciences Corporation
10.6.1 Exact Sciences Corporation Basic Information
10.6.2 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Overview
10.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Market Performance
10.6.4 Exact Sciences Corporation Business Overview
10.6.5 Exact Sciences Corporation Recent Developments
10.7 Foundation Medicine
10.7.1 Foundation Medicine Basic Information
10.7.2 Foundation Medicine Cell-free DNA Mutation Diagnostics Product Overview
10.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Product Market Performance
10.7.4 Foundation Medicine Business Overview
10.7.5 Foundation Medicine Recent Developments
10.8 Biocept
10.8.1 Biocept Basic Information
10.8.2 Biocept Cell-free DNA Mutation Diagnostics Product Overview
10.8.3 Biocept Cell-free DNA Mutation Diagnostics Product Market Performance
10.8.4 Biocept Business Overview
10.8.5 Biocept Recent Developments
10.9 Thermo Fisher Scientific
10.9.1 Thermo Fisher Scientific Basic Information
10.9.2 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Overview
10.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Market Performance
10.9.4 Thermo Fisher Scientific Business Overview
10.9.5 Thermo Fisher Scientific Recent Developments
10.10 Roche Diagnostics
10.10.1 Roche Diagnostics Basic Information
10.10.2 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Overview
10.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Market Performance
10.10.4 Roche Diagnostics Business Overview
10.10.5 Roche Diagnostics Recent Developments
10.11 Agilent Technologies
10.11.1 Agilent Technologies Basic Information
10.11.2 Agilent Technologies Cell-free DNA Mutation Diagnostics Product Overview
10.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Product Market Performance
10.11.4 Agilent Technologies Business Overview
10.11.5 Agilent Technologies Recent Developments
10.12 Quest Diagnostics Incorporated
10.12.1 Quest Diagnostics Incorporated Basic Information
10.12.2 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Overview
10.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Market Performance
10.12.4 Quest Diagnostics Incorporated Business Overview
10.12.5 Quest Diagnostics Incorporated Recent Developments
10.13 Laboratory Corporation of America Holdings
10.13.1 Laboratory Corporation of America Holdings Basic Information
10.13.2 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Overview
10.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Market Performance
10.13.4 Laboratory Corporation of America Holdings Business Overview
10.13.5 Laboratory Corporation of America Holdings Recent Developments
10.14 Myriad Genetics
10.14.1 Myriad Genetics Basic Information
10.14.2 Myriad Genetics Cell-free DNA Mutation Diagnostics Product Overview
10.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Product Market Performance
10.14.4 Myriad Genetics Business Overview
10.14.5 Myriad Genetics Recent Developments
10.15 BillionToOne
10.15.1 BillionToOne Basic Information
10.15.2 BillionToOne Cell-free DNA Mutation Diagnostics Product Overview
10.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Product Market Performance
10.15.4 BillionToOne Business Overview
10.15.5 BillionToOne Recent Developments
11 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Cell-free DNA Mutation Diagnostics Market Size Forecast
11.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell-free DNA Mutation Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Cell-free DNA Mutation Diagnostics Market Size Forecast by Region
11.2.4 South America Cell-free DNA Mutation Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell-free DNA Mutation Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell-free DNA Mutation Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell-free DNA Mutation Diagnostics by Type (2026-2035)
12.1.2 Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell-free DNA Mutation Diagnostics by Type (2026-2035)
12.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Cell-free DNA Mutation Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Cell-free DNA Mutation Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell-free DNA Mutation Diagnostics
1.2 Key Market Segments
1.2.1 Cell-free DNA Mutation Diagnostics Segment by Type
1.2.2 Cell-free DNA Mutation Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-free DNA Mutation Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell-free DNA Mutation Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell-free DNA Mutation Diagnostics Product Life Cycle
3.3 Global Cell-free DNA Mutation Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell-free DNA Mutation Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cell-free DNA Mutation Diagnostics Market Competitive Situation and Trends
3.8.1 Cell-free DNA Mutation Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell-free DNA Mutation Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL-FREE DNA MUTATION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Cell-free DNA Mutation Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-FREE DNA MUTATION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell-free DNA Mutation Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell-free DNA Mutation Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-free DNA Mutation Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Cell-free DNA Mutation Diagnostics Market Size by Type (2020-2025)
6.4 Global Cell-free DNA Mutation Diagnostics Price by Type (2020-2025)
7 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-free DNA Mutation Diagnostics Market Sales by Application (2020-2025)
7.3 Global Cell-free DNA Mutation Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Cell-free DNA Mutation Diagnostics Sales Growth Rate by Application (2020-2025)
8 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Cell-free DNA Mutation Diagnostics Sales by Region
8.1.1 Global Cell-free DNA Mutation Diagnostics Sales by Region
8.1.2 Global Cell-free DNA Mutation Diagnostics Sales Market Share by Region
8.2 Global Cell-free DNA Mutation Diagnostics Market Size by Region
8.2.1 Global Cell-free DNA Mutation Diagnostics Market Size by Region
8.2.2 Global Cell-free DNA Mutation Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Cell-free DNA Mutation Diagnostics Sales by Country
8.3.2 North America Cell-free DNA Mutation Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell-free DNA Mutation Diagnostics Sales by Country
8.4.2 Europe Cell-free DNA Mutation Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell-free DNA Mutation Diagnostics Sales by Region
8.5.2 Asia Pacific Cell-free DNA Mutation Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell-free DNA Mutation Diagnostics Sales by Country
8.6.2 South America Cell-free DNA Mutation Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell-free DNA Mutation Diagnostics Sales by Region
8.7.2 Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Cell-free DNA Mutation Diagnostics by Region(2020-2025)
9.2 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell-free DNA Mutation Diagnostics Production
9.4.1 North America Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell-free DNA Mutation Diagnostics Production
9.5.1 Europe Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell-free DNA Mutation Diagnostics Production (2020-2025)
9.6.1 Japan Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell-free DNA Mutation Diagnostics Production (2020-2025)
9.7.1 China Cell-free DNA Mutation Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Cell-free DNA Mutation Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Illumina
10.1.1 Illumina Basic Information
10.1.2 Illumina Cell-free DNA Mutation Diagnostics Product Overview
10.1.3 Illumina Cell-free DNA Mutation Diagnostics Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Natera
10.2.1 Natera Basic Information
10.2.2 Natera Cell-free DNA Mutation Diagnostics Product Overview
10.2.3 Natera Cell-free DNA Mutation Diagnostics Product Market Performance
10.2.4 Natera Business Overview
10.2.5 Natera SWOT Analysis
10.2.6 Natera Recent Developments
10.3 Guardant
10.3.1 Guardant Basic Information
10.3.2 Guardant Cell-free DNA Mutation Diagnostics Product Overview
10.3.3 Guardant Cell-free DNA Mutation Diagnostics Product Market Performance
10.3.4 Guardant Business Overview
10.3.5 Guardant SWOT Analysis
10.3.6 Guardant Recent Developments
10.4 Freenome Holdings
10.4.1 Freenome Holdings Basic Information
10.4.2 Freenome Holdings Cell-free DNA Mutation Diagnostics Product Overview
10.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Product Market Performance
10.4.4 Freenome Holdings Business Overview
10.4.5 Freenome Holdings Recent Developments
10.5 GRAIL
10.5.1 GRAIL Basic Information
10.5.2 GRAIL Cell-free DNA Mutation Diagnostics Product Overview
10.5.3 GRAIL Cell-free DNA Mutation Diagnostics Product Market Performance
10.5.4 GRAIL Business Overview
10.5.5 GRAIL Recent Developments
10.6 Exact Sciences Corporation
10.6.1 Exact Sciences Corporation Basic Information
10.6.2 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Overview
10.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Market Performance
10.6.4 Exact Sciences Corporation Business Overview
10.6.5 Exact Sciences Corporation Recent Developments
10.7 Foundation Medicine
10.7.1 Foundation Medicine Basic Information
10.7.2 Foundation Medicine Cell-free DNA Mutation Diagnostics Product Overview
10.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Product Market Performance
10.7.4 Foundation Medicine Business Overview
10.7.5 Foundation Medicine Recent Developments
10.8 Biocept
10.8.1 Biocept Basic Information
10.8.2 Biocept Cell-free DNA Mutation Diagnostics Product Overview
10.8.3 Biocept Cell-free DNA Mutation Diagnostics Product Market Performance
10.8.4 Biocept Business Overview
10.8.5 Biocept Recent Developments
10.9 Thermo Fisher Scientific
10.9.1 Thermo Fisher Scientific Basic Information
10.9.2 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Overview
10.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Market Performance
10.9.4 Thermo Fisher Scientific Business Overview
10.9.5 Thermo Fisher Scientific Recent Developments
10.10 Roche Diagnostics
10.10.1 Roche Diagnostics Basic Information
10.10.2 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Overview
10.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Market Performance
10.10.4 Roche Diagnostics Business Overview
10.10.5 Roche Diagnostics Recent Developments
10.11 Agilent Technologies
10.11.1 Agilent Technologies Basic Information
10.11.2 Agilent Technologies Cell-free DNA Mutation Diagnostics Product Overview
10.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Product Market Performance
10.11.4 Agilent Technologies Business Overview
10.11.5 Agilent Technologies Recent Developments
10.12 Quest Diagnostics Incorporated
10.12.1 Quest Diagnostics Incorporated Basic Information
10.12.2 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Overview
10.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Market Performance
10.12.4 Quest Diagnostics Incorporated Business Overview
10.12.5 Quest Diagnostics Incorporated Recent Developments
10.13 Laboratory Corporation of America Holdings
10.13.1 Laboratory Corporation of America Holdings Basic Information
10.13.2 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Overview
10.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Market Performance
10.13.4 Laboratory Corporation of America Holdings Business Overview
10.13.5 Laboratory Corporation of America Holdings Recent Developments
10.14 Myriad Genetics
10.14.1 Myriad Genetics Basic Information
10.14.2 Myriad Genetics Cell-free DNA Mutation Diagnostics Product Overview
10.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Product Market Performance
10.14.4 Myriad Genetics Business Overview
10.14.5 Myriad Genetics Recent Developments
10.15 BillionToOne
10.15.1 BillionToOne Basic Information
10.15.2 BillionToOne Cell-free DNA Mutation Diagnostics Product Overview
10.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Product Market Performance
10.15.4 BillionToOne Business Overview
10.15.5 BillionToOne Recent Developments
11 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Cell-free DNA Mutation Diagnostics Market Size Forecast
11.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell-free DNA Mutation Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Cell-free DNA Mutation Diagnostics Market Size Forecast by Region
11.2.4 South America Cell-free DNA Mutation Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell-free DNA Mutation Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell-free DNA Mutation Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell-free DNA Mutation Diagnostics by Type (2026-2035)
12.1.2 Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell-free DNA Mutation Diagnostics by Type (2026-2035)
12.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Cell-free DNA Mutation Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Cell-free DNA Mutation Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell-free DNA Mutation Diagnostics Market Size by Type (M USD)
Table 4. Global Cell-free DNA Mutation Diagnostics Market Size by Application
Table 5. Cell-free DNA Mutation Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Cell-free DNA Mutation Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell-free DNA Mutation Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell-free DNA Mutation Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free DNA Mutation Diagnostics as of 2025)
Table 11. Global Market Cell-free DNA Mutation Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cell-free DNA Mutation Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-free DNA Mutation Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell-free DNA Mutation Diagnostics Sales by Type (K Units)
Table 27. Global Cell-free DNA Mutation Diagnostics Market Size by Type (M USD)
Table 28. Global Cell-free DNA Mutation Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Cell-free DNA Mutation Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell-free DNA Mutation Diagnostics Market Share by Type (2020-2025)
Table 32. Global Cell-free DNA Mutation Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell-free DNA Mutation Diagnostics Sales (K Units) by Application
Table 34. Global Cell-free DNA Mutation Diagnostics Market Size by Application
Table 35. Global Cell-free DNA Mutation Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Cell-free DNA Mutation Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell-free DNA Mutation Diagnostics Market Share by Application (2020-2025)
Table 39. Global Cell-free DNA Mutation Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell-free DNA Mutation Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025)
Table 44. North America Cell-free DNA Mutation Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell-free DNA Mutation Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell-free DNA Mutation Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell-free DNA Mutation Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell-free DNA Mutation Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell-free DNA Mutation Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell-free DNA Mutation Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Cell-free DNA Mutation Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Illumina Basic Information
Table 63. Illumina Cell-free DNA Mutation Diagnostics Product Overview
Table 64. Illumina Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Illumina Business Overview
Table 66. Illumina SWOT Analysis
Table 67. Illumina Recent Developments
Table 68. Natera Basic Information
Table 69. Natera Cell-free DNA Mutation Diagnostics Product Overview
Table 70. Natera Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Natera Business Overview
Table 72. Natera SWOT Analysis
Table 73. Natera Recent Developments
Table 74. Guardant Basic Information
Table 75. Guardant Cell-free DNA Mutation Diagnostics Product Overview
Table 76. Guardant Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Guardant Business Overview
Table 78. Guardant SWOT Analysis
Table 79. Guardant Recent Developments
Table 80. Freenome Holdings Basic Information
Table 81. Freenome Holdings Cell-free DNA Mutation Diagnostics Product Overview
Table 82. Freenome Holdings Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Freenome Holdings Business Overview
Table 84. Freenome Holdings Recent Developments
Table 85. GRAIL Basic Information
Table 86. GRAIL Cell-free DNA Mutation Diagnostics Product Overview
Table 87. GRAIL Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. GRAIL Business Overview
Table 89. GRAIL Recent Developments
Table 90. Exact Sciences Corporation Basic Information
Table 91. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Overview
Table 92. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Exact Sciences Corporation Business Overview
Table 94. Exact Sciences Corporation Recent Developments
Table 95. Foundation Medicine Basic Information
Table 96. Foundation Medicine Cell-free DNA Mutation Diagnostics Product Overview
Table 97. Foundation Medicine Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Foundation Medicine Business Overview
Table 99. Foundation Medicine Recent Developments
Table 100. Biocept Basic Information
Table 101. Biocept Cell-free DNA Mutation Diagnostics Product Overview
Table 102. Biocept Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Biocept Business Overview
Table 104. Biocept Recent Developments
Table 105. Thermo Fisher Scientific Basic Information
Table 106. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Overview
Table 107. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Recent Developments
Table 110. Roche Diagnostics Basic Information
Table 111. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Overview
Table 112. Roche Diagnostics Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Roche Diagnostics Business Overview
Table 114. Roche Diagnostics Recent Developments
Table 115. Agilent Technologies Basic Information
Table 116. Agilent Technologies Cell-free DNA Mutation Diagnostics Product Overview
Table 117. Agilent Technologies Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Agilent Technologies Business Overview
Table 119. Agilent Technologies Recent Developments
Table 120. Quest Diagnostics Incorporated Basic Information
Table 121. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Overview
Table 122. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Quest Diagnostics Incorporated Business Overview
Table 124. Quest Diagnostics Incorporated Recent Developments
Table 125. Laboratory Corporation of America Holdings Basic Information
Table 126. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Overview
Table 127. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Laboratory Corporation of America Holdings Business Overview
Table 129. Laboratory Corporation of America Holdings Recent Developments
Table 130. Myriad Genetics Basic Information
Table 131. Myriad Genetics Cell-free DNA Mutation Diagnostics Product Overview
Table 132. Myriad Genetics Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Myriad Genetics Business Overview
Table 134. Myriad Genetics Recent Developments
Table 135. BillionToOne Basic Information
Table 136. BillionToOne Cell-free DNA Mutation Diagnostics Product Overview
Table 137. BillionToOne Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. BillionToOne Business Overview
Table 139. BillionToOne Recent Developments
Table 140. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Cell-free DNA Mutation Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Cell-free DNA Mutation Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Cell-free DNA Mutation Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Cell-free DNA Mutation Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell-free DNA Mutation Diagnostics Market Size by Type (M USD)
Table 4. Global Cell-free DNA Mutation Diagnostics Market Size by Application
Table 5. Cell-free DNA Mutation Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Cell-free DNA Mutation Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell-free DNA Mutation Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell-free DNA Mutation Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free DNA Mutation Diagnostics as of 2025)
Table 11. Global Market Cell-free DNA Mutation Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cell-free DNA Mutation Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-free DNA Mutation Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell-free DNA Mutation Diagnostics Sales by Type (K Units)
Table 27. Global Cell-free DNA Mutation Diagnostics Market Size by Type (M USD)
Table 28. Global Cell-free DNA Mutation Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Cell-free DNA Mutation Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell-free DNA Mutation Diagnostics Market Share by Type (2020-2025)
Table 32. Global Cell-free DNA Mutation Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell-free DNA Mutation Diagnostics Sales (K Units) by Application
Table 34. Global Cell-free DNA Mutation Diagnostics Market Size by Application
Table 35. Global Cell-free DNA Mutation Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Cell-free DNA Mutation Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell-free DNA Mutation Diagnostics Market Share by Application (2020-2025)
Table 39. Global Cell-free DNA Mutation Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell-free DNA Mutation Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025)
Table 44. North America Cell-free DNA Mutation Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell-free DNA Mutation Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell-free DNA Mutation Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell-free DNA Mutation Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell-free DNA Mutation Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell-free DNA Mutation Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell-free DNA Mutation Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Cell-free DNA Mutation Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell-free DNA Mutation Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Illumina Basic Information
Table 63. Illumina Cell-free DNA Mutation Diagnostics Product Overview
Table 64. Illumina Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Illumina Business Overview
Table 66. Illumina SWOT Analysis
Table 67. Illumina Recent Developments
Table 68. Natera Basic Information
Table 69. Natera Cell-free DNA Mutation Diagnostics Product Overview
Table 70. Natera Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Natera Business Overview
Table 72. Natera SWOT Analysis
Table 73. Natera Recent Developments
Table 74. Guardant Basic Information
Table 75. Guardant Cell-free DNA Mutation Diagnostics Product Overview
Table 76. Guardant Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Guardant Business Overview
Table 78. Guardant SWOT Analysis
Table 79. Guardant Recent Developments
Table 80. Freenome Holdings Basic Information
Table 81. Freenome Holdings Cell-free DNA Mutation Diagnostics Product Overview
Table 82. Freenome Holdings Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Freenome Holdings Business Overview
Table 84. Freenome Holdings Recent Developments
Table 85. GRAIL Basic Information
Table 86. GRAIL Cell-free DNA Mutation Diagnostics Product Overview
Table 87. GRAIL Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. GRAIL Business Overview
Table 89. GRAIL Recent Developments
Table 90. Exact Sciences Corporation Basic Information
Table 91. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Overview
Table 92. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Exact Sciences Corporation Business Overview
Table 94. Exact Sciences Corporation Recent Developments
Table 95. Foundation Medicine Basic Information
Table 96. Foundation Medicine Cell-free DNA Mutation Diagnostics Product Overview
Table 97. Foundation Medicine Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Foundation Medicine Business Overview
Table 99. Foundation Medicine Recent Developments
Table 100. Biocept Basic Information
Table 101. Biocept Cell-free DNA Mutation Diagnostics Product Overview
Table 102. Biocept Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Biocept Business Overview
Table 104. Biocept Recent Developments
Table 105. Thermo Fisher Scientific Basic Information
Table 106. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Overview
Table 107. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Recent Developments
Table 110. Roche Diagnostics Basic Information
Table 111. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Overview
Table 112. Roche Diagnostics Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Roche Diagnostics Business Overview
Table 114. Roche Diagnostics Recent Developments
Table 115. Agilent Technologies Basic Information
Table 116. Agilent Technologies Cell-free DNA Mutation Diagnostics Product Overview
Table 117. Agilent Technologies Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Agilent Technologies Business Overview
Table 119. Agilent Technologies Recent Developments
Table 120. Quest Diagnostics Incorporated Basic Information
Table 121. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Overview
Table 122. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Quest Diagnostics Incorporated Business Overview
Table 124. Quest Diagnostics Incorporated Recent Developments
Table 125. Laboratory Corporation of America Holdings Basic Information
Table 126. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Overview
Table 127. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Laboratory Corporation of America Holdings Business Overview
Table 129. Laboratory Corporation of America Holdings Recent Developments
Table 130. Myriad Genetics Basic Information
Table 131. Myriad Genetics Cell-free DNA Mutation Diagnostics Product Overview
Table 132. Myriad Genetics Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Myriad Genetics Business Overview
Table 134. Myriad Genetics Recent Developments
Table 135. BillionToOne Basic Information
Table 136. BillionToOne Cell-free DNA Mutation Diagnostics Product Overview
Table 137. BillionToOne Cell-free DNA Mutation Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. BillionToOne Business Overview
Table 139. BillionToOne Recent Developments
Table 140. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Cell-free DNA Mutation Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Cell-free DNA Mutation Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Cell-free DNA Mutation Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Cell-free DNA Mutation Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell-free DNA Mutation Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-free DNA Mutation Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Cell-free DNA Mutation Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Cell-free DNA Mutation Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-free DNA Mutation Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell-free DNA Mutation Diagnostics Product Life Cycle
Figure 13. Cell-free DNA Mutation Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Cell-free DNA Mutation Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell-free DNA Mutation Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell-free DNA Mutation Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Cell-free DNA Mutation Diagnostics
Figure 19. Global Cell-free DNA Mutation Diagnostics Market PEST Analysis
Figure 20. Global Cell-free DNA Mutation Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell-free DNA Mutation Diagnostics Market Share by Type
Figure 27. Sales Market Share of Cell-free DNA Mutation Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Cell-free DNA Mutation Diagnostics by Type in 2025
Figure 29. Market Share of Cell-free DNA Mutation Diagnostics by Type (2020-2025)
Figure 30. Market Share of Cell-free DNA Mutation Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell-free DNA Mutation Diagnostics Market Share by Application
Figure 33. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Cell-free DNA Mutation Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Cell-free DNA Mutation Diagnostics Market Share by Application in 2025
Figure 37. Global Cell-free DNA Mutation Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell-free DNA Mutation Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell-free DNA Mutation Diagnostics Market Size by Country in 2024
Figure 45. U.S. Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell-free DNA Mutation Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell-free DNA Mutation Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell-free DNA Mutation Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell-free DNA Mutation Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell-free DNA Mutation Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell-free DNA Mutation Diagnostics Market Size by Country in 2024
Figure 55. Germany Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell-free DNA Mutation Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell-free DNA Mutation Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell-free DNA Mutation Diagnostics Market Size by Region in 2024
Figure 68. China Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell-free DNA Mutation Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Cell-free DNA Mutation Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Cell-free DNA Mutation Diagnostics Market Size by Country in 2024
Figure 82. Brazil Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell-free DNA Mutation Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell-free DNA Mutation Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cell-free DNA Mutation Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-free DNA Mutation Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Cell-free DNA Mutation Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Cell-free DNA Mutation Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-free DNA Mutation Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell-free DNA Mutation Diagnostics Product Life Cycle
Figure 13. Cell-free DNA Mutation Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Cell-free DNA Mutation Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell-free DNA Mutation Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell-free DNA Mutation Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Cell-free DNA Mutation Diagnostics
Figure 19. Global Cell-free DNA Mutation Diagnostics Market PEST Analysis
Figure 20. Global Cell-free DNA Mutation Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell-free DNA Mutation Diagnostics Market Share by Type
Figure 27. Sales Market Share of Cell-free DNA Mutation Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Cell-free DNA Mutation Diagnostics by Type in 2025
Figure 29. Market Share of Cell-free DNA Mutation Diagnostics by Type (2020-2025)
Figure 30. Market Share of Cell-free DNA Mutation Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell-free DNA Mutation Diagnostics Market Share by Application
Figure 33. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Cell-free DNA Mutation Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Cell-free DNA Mutation Diagnostics Market Share by Application in 2025
Figure 37. Global Cell-free DNA Mutation Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell-free DNA Mutation Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell-free DNA Mutation Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell-free DNA Mutation Diagnostics Market Size by Country in 2024
Figure 45. U.S. Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell-free DNA Mutation Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell-free DNA Mutation Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell-free DNA Mutation Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell-free DNA Mutation Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell-free DNA Mutation Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell-free DNA Mutation Diagnostics Market Size by Country in 2024
Figure 55. Germany Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell-free DNA Mutation Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell-free DNA Mutation Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell-free DNA Mutation Diagnostics Market Size by Region in 2024
Figure 68. China Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell-free DNA Mutation Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Cell-free DNA Mutation Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Cell-free DNA Mutation Diagnostics Market Size by Country in 2024
Figure 82. Brazil Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell-free DNA Mutation Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell-free DNA Mutation Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell-free DNA Mutation Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell-free DNA Mutation Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell-free DNA Mutation Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell-free DNA Mutation Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell-free DNA Mutation Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell-free DNA Mutation Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Application (2026-2035)
